PMID- 29439646 OWN - NLM STAT- MEDLINE DCOM- 20180925 LR - 20180925 IS - 1477-0962 (Electronic) IS - 0961-2033 (Linking) VI - 27 IP - 6 DP - 2018 May TI - The influence of functional polymorphic positions of HLA-DRbeta1 molecules on risk for South Indian systemic lupus erythematosus patients. PG - 991-1000 LID - 10.1177/0961203318759200 [doi] AB - The aim of this case-control study was to investigate the association of human leukocyte antigen (HLA) Class II alleles with the susceptibility and phenotypic heterogeneity in systemic lupus erythematosus (SLE) in South Indian patients. A total of 439 individuals (212 SLE cases and 227 age- and ethnicity-matched controls) were included in the study. The genotyping of HLA-DRbeta1 and - DQbeta1 was conducted by the PCR-SSP method. HLA-DRbeta1*07 was significantly associated with SLE (OR: 2.02; 95% CI: 1.34-3.04, p = 1.50 x 10(-4), p(c) = 1.95 x 10(-3)), whereas the DRbeta1*14 allele was negatively associated with SLE (OR: 0.49; 95% CI: 0.31-0.76, p = 1.70 x 10(-2), p(c) = 0.221). In addition, the HLA-DRbeta1*07/15 genotype tended to be positively associated with SLE (OR: 3.23, 95% CI: 1.57-6.63, p = 0.0009). Amino acid residues residing in the peptide-binding pocket of HLA-DRbeta1 play a significant role in peptide recruitment and antigen presentation. Our results demonstrated that amino acid glycine 11 (OR: 2.11, 95% CI: 1.42-3.12, p(c) = 0.00093), tyrosine 13 (OR: 2.11, 95% CI: 1.42-3.12, p(c) = 0.00062) and glutamine 74 (OR: 2.11, 95% CI: 1.42-3.12, p(c) = 0.00077) showed a significant positive association with SLE. Certain haplotype combinations, DRB1*07-DQbeta1*03 (OR: 2.21; 95% CI:1.29-3.79, p(c) = 0.06, p = 0.00036) and DRbeta1*07-DQbeta1*05 (OR: 2.51, 95% CI: 1.34-4.71, p(c) = 0.07, p = 0.00039), had positive associations whereas DRbeta1*14-DQbeta1*03 (OR: 0.14, 95% CI: 0.061-0.36, p(c) = 2.34 x 10(-5), p = 1.30 x 10(-6)) were found to have a significant negative association with SLE. So far, the present study is the first attempt to investigate the association of HLA-DRbeta1 and - DQbeta1 allele, genotype and haplotype combinations with the risk of SLE in South Indian patients. In conclusion, the HLA-DRbeta1*07 allele is associated with risk of SLE whereas a protective association of HLA-DRbeta1*14 alleles with SLE was observed. FAU - Katkam, S K AU - Katkam SK AD - 1 Department of Clinical Pharmacology and Therapeutics, 28605 Nizam's Institute of Medical Sciences (NIMS) , Telangana, Hyderabad, India. FAU - Rajasekhar, L AU - Rajasekhar L AD - 2 Department of Clinical Immunology and Rheumatology, 28605 Nizam's Institute of Medical Sciences (NIMS) , Telangana, Hyderabad, India. FAU - Kutala, V K AU - Kutala VK AD - 1 Department of Clinical Pharmacology and Therapeutics, 28605 Nizam's Institute of Medical Sciences (NIMS) , Telangana, Hyderabad, India. LA - eng PT - Journal Article DEP - 20180213 PL - England TA - Lupus JT - Lupus JID - 9204265 RN - 0 (HLA-DQ beta-Chains) RN - 0 (HLA-DQB1 antigen) RN - 0 (HLA-DRB1 Chains) RN - 0 (HLA-DRB1*07 antigen) SB - IM MH - Adult MH - Case-Control Studies MH - Female MH - Gene Frequency MH - Genetic Association Studies MH - Genetic Predisposition to Disease MH - HLA-DQ beta-Chains/genetics/immunology MH - HLA-DRB1 Chains/*genetics/immunology MH - Haplotypes MH - Humans MH - India/epidemiology MH - Lupus Erythematosus, Systemic/diagnosis/ethnology/*genetics/immunology MH - Male MH - Odds Ratio MH - Phenotype MH - *Polymorphism, Single Nucleotide MH - Protective Factors MH - Risk Factors MH - Young Adult OTO - NOTNLM OT - Systemic lupus erythematosus OT - autoantibody OT - autoimmune disease OT - human leukocyte antigen OT - major histocompatibility complex OT - polymorphism EDAT- 2018/02/15 06:00 MHDA- 2018/09/27 06:00 CRDT- 2018/02/15 06:00 PHST- 2018/02/15 06:00 [pubmed] PHST- 2018/09/27 06:00 [medline] PHST- 2018/02/15 06:00 [entrez] AID - 10.1177/0961203318759200 [doi] PST - ppublish SO - Lupus. 2018 May;27(6):991-1000. doi: 10.1177/0961203318759200. Epub 2018 Feb 13.